Search

everythinglearnresearchcommunity

for

Search:↓

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Antibody treatments show promise for hair loss but need more research.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Castration significantly reduces prostate size and BPH symptoms.

Kigelia africana fruit extract can prevent and reverse prostate enlargement in rats.

Metallothionein likely helps in cell growth and development in wool follicles of fetal sheep.

New compounds may help treat prostate issues without affecting androgen receptors.

S100A6 is important for cell functions and can help diagnose and treat diseases.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

A new method was developed to accurately measure enzyme activity related to prostate health.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.